Matthew Sinnreich

Insider Reports History

Location
Miami Beach, FL
Signature
/s/ Dale S. Bergman as attorney-in-fact for Matthew Sinnreich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Sinnreich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Organicell Regenerative Medicine, Inc. President and Acting CEO, Director Common Stock, $0.001 par value 0 $1.32 31 Oct 2022 Indirect

Insider Reports Filed by Matthew Sinnreich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCEL Organicell Regenerative Medicine, Inc. 31 Oct 2022 1 $0 4/A President and Acting CEO, Director 03 Nov 2022, 17:01
OCEL Organicell Regenerative Medicine, Inc. 13 Oct 2022 1 -$800 4 President and Acting CEO, Director 17 Oct 2022, 06:00
OCEL Organicell Regenerative Medicine, Inc. 21 Jul 2022 0 $0 3 COO and Acting CEO 26 Jul 2022, 16:05